Sheller in Chronicle of Higher Education on Major Drug Fraud
The Chronicle of Higher Education 2013-11-08 Federal prosecutors on Thursday concluded another multibillion-dollar settlement with a major pharmaceutical company accused of illegally marketing its drugs. In this case, the company was Johnson & Johnson, the total payment was $2.2-billion, and the key drug was Risperdal, which was approved by federal regulators to treat schizophrenia in […]
$1.4 Billion Whistleblower Settlement
2009-01-15 Sheller, P.C.’s whistleblower/qui tam clients help U.S. government recover $1.4 billion record settlement and criminal fine in Eli Lilly & Company Zyprexa marketing case. [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/ShellerPC_ZyprexaNewsRelease_200901152.pdf”]
